701 results on '"Marret, S."'
Search Results
152. Croissance fœtale du prématuré de Haute-Normandie
153. Anomalies de la croissance de l'épithélium neural induites par la caféine dans un modèle de cultures d'embryons in toto de la souris
154. Developmental spectrum of the excitotoxic cascade induced by ibotenate: a model of hypoxic insults in fetuses and neonates
155. Lésions excitotoxiques de la substance blanche. Mécanismes physiopathologiques et effets neuroprotecteurs du VIP
156. Neuroprotection of Excitotoxic Brain Lesions in the Newborn Mouse by Glycine Antagonist and Inhibitor of No °. 159
157. Le développement et les apprentissages
158. Les indications d'une intervention précoce dans la prévention et la prise en charge des anomalies neuro-développementales
159. La prévention par le magnésium des dysgénésies cérébrales excitotoxiques au cours du développement chez la souris
160. P02 La maladie de letterer-siwe. A propos d'un cas à revelation neonatale
161. P78 Une neurofibromatose de type 1 a revelation antenatale
162. Effect of ibotenate on brain development: Excitotoxic mouse model of microgyria and posthypoxiclike lesions
163. Delayed development at 1 year in very preterm infants: the epipage cohort study
164. Herpes simplex hepatitis with chronic cholestasis in a newborn
165. Positive rolandic sharp waves in the EEG of the premature newborn: a five year prospective study.
166. Neonatal factors associated with alteration of palatal morphology in very preterm children: The EPIPAGE cohort study.
167. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.
168. Hyaluronan synthesis by astrocytes in newborn rat brain cell cultures
169. Congenital Nephrotic Syndrome in a Male Pseudohermaphrodite - The Drash Syndrome
170. Prenatal revelation of Niemann-Pick disease type C in siblings.
171. Prolonged sedation and/or analgesia and 5-year neurodevelopment outcome in very preterm infants: results from the EPIPAGE cohort.
172. Prevalence and associated factors of minor neuromotor dysfunctions at age 5 years in prematurely born children: the EPIPAGE Study.
173. Neonatal and 5-year outcomes after birth at 30-34 weeks of gestation.
174. Are maternal hypertension and small-for-gestational age risk factors for severe intraventricular hemorrhage and cystic periventricular leukomalacia? Results of the EPIPAGE cohort study.
175. Prenatal risk factors for cerebral palsy in very preterm singletons and twins.
176. Positive Rolandic Sharp Waves and Periventricular Leukomalacia in the Newborn.
177. CNS myelinogenesis in vitro: Time course and pattern of rat oligodendrocyte development.
178. Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies.
179. Intracerebral Inflammatory Pseudotumour in a 16-Month-Old Boy
180. Ce que pensent les néonatalogistes des césariennes programmées « à terme ».
181. Indications for early intervention in prevention and management of neurodevelopmental disorders
182. Goldenhar syndrome and neuroblastoma: a chance association?
183. Caffeine-induced disturbances of early neurogenesis in whole mouse embryo cultures
184. Long-term evolution of excitotoxic cortical dysgenesis induced in the developing rat brain
185. Enterovirus-associated haemophagocytic syndrome in a neonate.
186. Erratum: Local and global attention are mapped retinotopically in human occipital cortex (Proceedings of the National Academy of Sciences of the United States of America (February 13, 2001) 98:4 (2077-2082))
187. Tocolytic magnesium sulphate and paediatric mortality [2]
188. Neurodevelopmental Outcome at 2 Years for Preterm Children Born at 22 to 34 Weeks’ Gestation in France in 2011: EPIPAGE-2 Cohort Study
189. Leading Causes of Preterm Delivery as Risk Factors for Intraventricular Hemorrhage in Very Preterm Infants: Results of the EPIPAGE 2 Cohort Study
190. Le sulfate de magnésium : une avancée dans le domaine de la protection cérébrale de l’enfant né prématuré
191. Devenir neurodéveloppemental après un infarctus cérébral artériel néonatal.
192. Plasticité cérébrale et prise en charge rééducative précoce des enfants après infarctus cérébral artériel néonatal.
193. Danger du Nifluril ® pendant la grossesse: un cas d'insuffisance rénale chronique à début anténatal
194. Antenatal magnesium sulphate to prevent cerebral palsy in very preterm infants.
195. P26 – 2068 Epilepsy and learning disorders.
196. The Influence of Fetal Growth Reference Standards on Assessment of Cognitive and Academic Outcomes of Very Preterm Children.
197. Mouvements anormaux paroxystiques du nouveau-né à terme
198. Height at 2 and 5 years of age in children born very preterm: the EPIPAGE study.
199. Congenital rubella with bilateral cataract detected at 5 weeks.
200. MAGNESIUM SULPHATE GIVEN FOR NEUROPROTECTION BEFORE PRETERM BIRTH
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.